查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1540897

2024-2032 年按测试类型、适应症、产品、技术（聚合酶炼式反应、下一代定序、免疫分析等）、应用和地区分類的生物标记技术市场报告

Biomarker Technologies Market Report by Test Type, Indication, Product, Technology (Polymerase Chain Reaction, Next Generation Sequencing, Immunoassay, and Others), Application, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3个工作天内

价格

IMARC Group年，全球生物标记技术市场规模达到402亿美元。在医疗保健、製药和诊断领域的应用不断增加，加上对精准医学和疾病检测的日益关注以及对非侵入性诊断方法的需求不断增长的推动下，该市场正在经历稳定增长。

生物标记技术市场分析：

市场成长与规模：在医疗保健、製药和诊断领域不断增加的应用的推动下，该市场目前正在稳定成长。此外，生物标记技术与研发 (R&D) 流程的整合进一步推动了这种稳定成长，增强了其在推动医疗保健、製药和诊断方面的关键作用。

对非侵入性诊断方法的需求不断增长：市场见证了对非侵入性诊断方法的需求不断增加，这是由于其患者友善性、准确性和无需侵入性程序即可检测疾病的有效性。

产业应用：市场正经历医疗保健、製药和诊断等不同行业的高需求，凸显了它们的多功能性和广泛采用。

地理趋势：北美由于其强大的基础设施、对研发的大量投资以及对医疗保健创新的高度重视，在生物标记技术市场上处于领先地位。

竞争格局：市场的特点是竞争激烈，主要参与者专注于创新和扩大市场份额，导致生物标记技术不断进步。

挑战与机会：虽然监管障碍带来了挑战，但它也带来了个人化医疗和诊断突破，为产业参与者提供了令人兴奋的机会。

未来展望：生物标记技术市场的未来看起来充满希望，特别是在个人化医疗和增强疾病检测领域。

生物标记技术市场趋势：

精准医疗需求不断成长

对精准医疗不断增长的需求是生物标记技术市场的主要驱动力。精准医学代表了医疗保健领域的典范转移，旨在根据患者独特的遗传、分子和临床特征为其提供个人化治疗策略。生物标誌物在这一转变中发挥关键作用。它们是反映体内各种生物过程的可测量指标。在精准医学的背景下，它们是识别特定疾病亚型、预测疾病进展和确定最有效治疗方法的重要工具。透过分析生物标誌物，医疗保健专业人员可以针对个别患者量身定制干预措施，优化治疗结果，同时最大限度地减少潜在的副作用。精准医学最引人注目的方面之一是它彻底改变癌症治疗的潜力。生物标记技术使肿瘤学家能够识别肿瘤中的基因突变和蛋白质标记，从而能够选择专门针对癌症潜在分子驱动因素的标靶疗法。这增加了成功治疗的机会，减少了反覆试验的需要，使患者免受无效治疗和不必要的毒性的影响，从而推动市场成长。

组学技术的进步

组学技术的进步是生物标记技术市场的另一个重要驱动力。组学涵盖各种科学学科，包括基因组学、蛋白质组学和代谢组学，每个学科在生物标记的发现和开发中都发挥着至关重要的作用。基因组学涉及对个体完整 DNA 集的研究，提供与疾病相关的遗传变异和突变的见解。 DNA 定序技术的不断进步使得基因组分析变得更快、更具成本效益，从而识别出与各种状况相关的众多遗传生物标记。如此丰富的基因组资料扩大了个人化医疗和标靶治疗开发的潜力。蛋白质体学专注于生物系统内蛋白质的研究。质谱分析和其他创新的蛋白质体学技术使研究人员能够识别与疾病或治疗反应相关的特定蛋白质生物标记。这些生物标记对于改善疾病诊断、监测和药物开发具有巨大的前景。代谢组学检查生物样本中的小分子和代谢物，揭示代谢途径和失调。因此，组学技术的进步不断丰富生物标记工具箱，促进新生物标记的发现，增强我们对疾病的理解，并推动诊断和药物开发的创新。

慢性病负担增加

慢性病负担不断增加是推动生物标记技术市场成长的重要因素。心血管疾病、糖尿病、癌症和呼吸系统疾病等慢性疾病是日益严重的全球健康挑战。人口老化、生活方式的改变和环境因素等因素导致这些疾病的盛行率不断增加。生物标记技术已成为对抗慢性病的关键工具。它们提供了早期准确检测的潜力，这对于有效的疾病管理和改善患者的治疗效果至关重要。生物标记可以识别身体的细微变化，这些变化可能表明慢性疾病的发作或进展，通常在临床症状出现之前。这种早期检测使医疗保健专业人员能够及时介入、实施个人化治疗计划并更密切地监测疾病进展。随着全球慢性病负担持续增加，对支持早期检测、精确监测和个人化治疗策略的生物标记技术的需求不断增加。

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 数据来源
    • 主要来源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：简介

  • 概述
  • 主要行业趋势

第 5 章：全球生物标记技术市场

  • 市场概况
  • 市场表现
  • COVID-19 的影响
  • 市场预测

第 6 章：市场区隔：按测试类型

  • 实体切片
    • 市场趋势
    • 市场预测
  • 液体活检
    • 市场趋势
    • 市场预测

第 7 章：市场区隔：依迹象

  • 癌症
    • 市场趋势
    • 市场预测
  • 传染病
    • 市场趋势
    • 市场预测
  • 自体免疫疾病
    • 市场趋势
    • 市场预测
  • 心血管疾病
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 8 章：市场区隔：依产品

  • 耗材
    • 市场趋势
    • 市场预测
  • 测定
    • 市场趋势
    • 市场预测
  • 试剂
    • 市场趋势
    • 市场预测
  • 仪器仪表
    • 市场趋势
    • 市场预测

第 9 章：市场区隔：依技术

  • 聚合酶炼式反应 (PCR)
    • 市场趋势
    • 市场预测
  • 次世代定序 (NGS)
    • 市场趋势
    • 市场预测
  • 免疫分析
    • 市场趋势
    • 市场预测
  • 其他的
    • 市场趋势
    • 市场预测

第 10 章：市场区隔：按应用

  • 药物发现
    • 市场趋势
    • 市场预测
  • 临床诊断
    • 市场趋势
    • 市场预测
  • 个人化医疗
    • 市场趋势
    • 市场预测

第 11 章：市场区隔：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲
    • 市场趋势
    • 市场细分：按国家/地区
    • 市场预测

第 12 章：SWOT 分析

  • 概述
  • 优势
  • 弱点
  • 机会
  • 威胁

第 13 章：价值链分析

第 14 章：波特五力分析

  • 概述
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第 15 章：价格分析

第16章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Agilent Technologies Inc.
    • Bio-Rad Laboratories Inc.
    • Danaher Corporation
    • F. Hoffmann-La Roche AG
    • Illumina Inc.
    • LI-COR Inc.
    • Merck KGaA
    • PerkinElmer Inc.
    • QIAGEN NV
    • Shimadzu Corporation
    • Thermo Fisher Scientific Inc.
    • Waters Corporation
Product Code: SR112024A4341

The global biomarker technologies market size reached US$ 40.2 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 113.4 Billion by 2032, exhibiting a growth rate (CAGR) of 11.8% during 2024-2032. The market is experiencing steady growth, driven by increasing applications in healthcare, pharmaceuticals, and diagnostics, coupled with a heightening focus on precision medicine and disease detection and the rising demand for non-invasive diagnostic methods.

Biomarker Technologies Market Analysis:

Market Growth and Size: The market is currently witnessing stable growth, fueled by its increasing applications in healthcare, pharmaceuticals, and diagnostics. Additionally, the integration of biomarker technologies into research and development (R&D) processes further fuels this stable growth, enhancing their pivotal role in advancing healthcare, pharmaceuticals, and diagnostics.

Rising Demand for Non-Invasive Diagnostic Methods: The market witnesses an increasing demand for non-invasive diagnostic methods, driven by their patient-friendly nature, accuracy, and effectiveness in detecting diseases without the need for invasive procedures.

Industry Applications: The market is experiencing high demand from diverse industries, including healthcare, pharmaceuticals, and diagnostics, highlighting their versatility and widespread adoption.

Geographical Trends: North America leads the biomarker technologies market due to its robust infrastructure, significant investments in research and development, and a strong focus on healthcare innovation.

Competitive Landscape: The market is characterized by intense competition with key players focusing on innovation and expanding their market share, resulting in continuous advancements in biomarker technology.

Challenges and Opportunities: While regulatory hurdles present challenges, it also promises of personalized medicine and diagnostic breakthroughs that offers exciting opportunities for industry players.

Future Outlook: The future of the biomarker technologies market looks promising, especially in the realms of personalized medicine and enhanced disease detection.

Biomarker Technologies Market Trends:

Growing demand for precision medicine

The growing demand for precision medicine is a maior driving force in the biomarker technologies market. Precision medicine represents a paradigm shift in healthcare, aiming to provide personalized treatment strategies for patients based on their unique genetic, molecular, and clinical characteristics. Biomarkers play a pivotal role in this transformation. They are measurable indicators that reflect various biological processes within the body. In the context of precision medicine, they serve as crucial tools for identifying specific disease subtypes, predicting disease progression, and determining the most effective treatment approaches. By analyzing biomarkers, healthcare professionals can tailor interventions to individual patients, optimizing therapeutic outcomes while minimizing potential side effects. One of the most compelling aspects of precision medicine is its potential to revolutionize cancer care. Biomarker technologies allow oncologists to identify genetic mutations and protein markers in tumors, enabling the selection of targeted therapies that specifically address the underlying molecular drivers of cancer. This increases the chances of successful treatment and reduces the need for trial-and-error approaches, sparing patients from ineffective therapies and unnecessary toxicity, thereby fueling market growth.

Advancements in omics technologies

Advancements in omics technologies represent another significant driver in the biomarker technologies market. Omics encompasses various scientific disciplines, including genomics, proteomics, and metabolomics, each of which plays a crucial role in biomarker discovery and development. Genomics involves the study of an individual's complete set of DNA, providing insights into genetic variations and mutations associated with diseases. Ongoing advancements in DNA sequencing technologies have made it faster and more cost-effective to analyze the genome, leading to the identification of numerous genetic biomarkers linked to various conditions. This wealth of genomic data expands the potential for personalized medicine and the development of targeted therapies. Proteomics focuses on the study of proteins within biological systems. Mass spectrometry and other innovative proteomic techniques enable researchers to identify specific protein biomarkers associated with diseases or treatment responses. These biomarkers hold immense promise for improving disease diagnosis, monitoring, and drug development. Metabolomics examines the small molecules and metabolites in biological samples, shedding light on metabolic pathways and dysregulations. As a result, advancements in omics technologies continue to enrich the biomarker toolbox, facilitating the discovery of new biomarkers, enhancing our understanding of diseases, and driving innovation in diagnostics and drug development.

Increasing burden of chronic diseases

The escalating burden of chronic diseases is a significant factor propelling the growth of the biomarker technologies market. Chronic diseases, such as cardiovascular diseases, diabetes, cancer, and respiratory disorders, are a growing global health challenge. Factors like aging populations, lifestyle changes, and environmental factors contribute to the increasing prevalence of these conditions. Biomarker technologies have emerged as critical tools in the battle against chronic diseases. They offer the potential for early and accurate detection, which is crucial for effective disease management and improved patient outcomes. Biomarkers can identify subtle changes in the body that may indicate the onset or progression of a chronic disease, often before clinical symptoms manifest. This early detection empowers healthcare professionals to intervene promptly, implement personalized treatment plans, and monitor disease progression more closely. As the burden of chronic diseases continues to rise globally, there has been a heightened demand for biomarker technologies that support early detection, precise monitoring, and personalized treatment strategies.

Biomarker Technologies Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on indication, product, technology and application.

Breakup by Test Type:

Solid Biopsy

Liquid Biopsy

Liquid biopsy accounts for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the test type. This includes solid biopsy and liquid biopsy. According to the report, liquid biopsy represented the largest segment.

Liquid biopsy has emerged as a transformative force in the biomarker technologies market. This non-invasive method involves analyzing biomarkers present in bodily fluids, such as blood or urine, to detect diseases, particularly cancer. Liquid biopsies offer numerous advantages, including early disease detection, real-time monitoring, and the ability to track treatment response. They reduce the need for invasive procedures and provide valuable information on tumor heterogeneity. As the demand for less invasive and more accessible diagnostic methods increases, liquid biopsies are driving the market further by expanding applications beyond traditional tissue-based biopsies and revolutionizing the field of diagnostics. Their potential to improve patient care and outcomes makes them a key market driver.

Solid biopsy methods involve the extraction of tissue samples from tumors or other abnormal growths for analysis. Solid biopsies provide essential biomarker data that guide treatment decisions, especially in cancer care. They also enable the identification of specific genetic, protein, or molecular markers, aiding in the selection of targeted therapies and predicting treatment responses. As precision medicine gains prominence, solid biopsy-derived biomarkers become indispensable, contributing to the market growth. Advancements in solid biopsy techniques, such as minimally invasive procedures, improve patient comfort and further fuel their adoption rate.

Breakup by Indication:

Cancer

Infectious Diseases

Autoimmune Disorders

Cardiovascular Disorders

Others

Cancer holds the largest share in the industry

A detailed breakup and analysis of the market based on the indication have also been provided in the report. This includes cancer, infectious diseases, autoimmune diseases, cardiovascular diseases, and others. According to the report, cancer accounted for the largest market share.

Biomarker technologies are instrumental in the fight against cancer, providing essential tools for early detection, precise diagnosis, and tailored treatment strategies. They enable the identification of specific genetic and molecular markers, improving patient outcomes and driving substantial market growth in the oncology sector. They also play a crucial role in infectious disease management by facilitating rapid and accurate pathogen detection, monitoring treatment responses, and aiding in epidemiological studies, contributing significantly to the market's expansion, particularly in the context of global health crises.

Biomarker technologies are pivotal in diagnosing and monitoring autoimmune disorders, offering insights into disease progression and treatment efficacy, thus driving their adoption and furthering research in autoimmune disease management.

Biomarkers are indispensable in assessing cardiovascular health and risk factors. Their use in early diagnosis, monitoring, and personalized treatment plans fuels the demand for biomarker technologies, leading to advancements in cardiovascular care and fostering market growth.

Breakup by Product:

Consumables

Assay

Reagent

Instruments

Consumables represent the leading market segment

The report has provided a detailed breakup and analysis of the market based on the product. This includes consumables, assay, reagent, and instruments. According to the report, consumables represented the largest segment.

Consumables, including sample collection kits and containers, are vital components of biomarker technology workflows. They are essential for collecting and preserving biological samples, making them indispensable for research, diagnostics, and drug development. The steady demand for these consumables ensures a consistent revenue stream in the biomarker technologies market.

Assays are at the heart of biomarker analysis. They encompass a wide range of techniques, such as ELISA and PCR, used to detect and quantify specific biomarkers. The development of innovative assay methods and kits further catalyzed market growth as they enable more precise and efficient biomarker detection.

Reagents are essential chemical compounds used in various stages of biomarker analysis. They play a critical role in sample preparation, labeling, and detection. The continuous need for high-quality reagents, especially for emerging biomarkers, fuels market demand, making reagents a lucrative segment.

Biomarker detection instruments, such as mass spectrometers and PCR machines, are the technological backbone of biomarker analysis. Advances in instrument capabilities, including sensitivity and throughput, significantly impact market growth. As research and diagnostic needs evolve, there has been a rise in the demand for cutting-edge biomarker detection instruments.

Breakup by Technology:

Polymerase Chain Reaction (PCR)

Next Generation Sequencing (NGS)

Immunoassay

Others

Immunoassay accounts for the majority of market share

The report has provided a detailed breakup and analysis of the market based on the technology. This includes polymerase chain reaction (PCR), next generation sequencing (NGS), immunoassay, and others. According to the report, immunoassay represented the largest segment.

Immunoassays are key for detecting protein biomarkers. They offer specificity, making them crucial in clinical diagnostics and research. Constant innovation in immunoassay platforms and reagents continues to propel the biomarker technologies market forward, enhancing biomarker detection sensitivity and precision.

Polymerase Chain Reaction (PCR) technology revolutionized biomarker analysis by enabling the amplification of DNA sequences. It plays a pivotal role in identifying genetic biomarkers, offering high specificity and sensitivity. Its versatility in applications, from disease diagnostics to gene expression analysis, ensures its enduring importance in the biomarker technologies market.

Next Generation Sequencing (NGS) technology enables comprehensive genomic and transcriptomic analysis. It contributes to biomarker discovery by identifying genetic variations associated with diseases. Its ability to process large datasets rapidly has accelerated research, making NGS a major driving force in biomarker-related advancements.

Breakup by Application:

Drug Discovery

Clinical Diagnostics

Personalized Medicine

Drug discovery represents the leading market segment

The report has provided a detailed breakup and analysis of the market based on the application. This includes drug discovery, clinical diagnostics, and personalized medicine. According to the report, drug discovery represented the largest segment.

Biomarker technologies are indispensable in drug discovery, aiding in target identification, validation, and efficacy assessment. They streamline the drug development process by identifying potential therapeutic targets and predicting drug responses, reducing costs and accelerating time to market.

In clinical diagnostics, biomarkers play a pivotal role in disease diagnosis, prognosis, and treatment monitoring. Their use enhances healthcare by enabling early disease detection and personalized treatment plans, spurring the adoption of biomarker technologies in clinical settings, ultimately improving patient outcomes.

Biomarker technologies are the cornerstone of personalized medicine, allowing healthcare providers to tailor treatments based on individual patient profiles. This approach improves treatment efficacy, reduces adverse effects, and fosters patient-centric healthcare, thus fueling the growth of biomarker technologies in personalized medicine applications, revolutionizing healthcare delivery.

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America leads the market, accounting for the largest biomarker technologies market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America held the biggest market share since the region boasts a robust infrastructure, significant R&D investments, and a focus on healthcare innovation. The region's commitment to cutting-edge research and clinical applications positions it as a key driver of biomarker technology advancement.

Asia Pacific is also an expanding market for biomarker technologies owing to increasing healthcare investments, growing research capabilities, and a rising burden of chronic diseases. The region's emphasis on precision medicine and personalized healthcare drives demand for biomarker-based diagnostics and treatment strategies.

Europe's biomarker technologies market benefits from strong collaborations between academia and industry. It thrives on the continent's commitment to healthcare innovation, making it a prominent player in biomarker research and application development.

Biomarker technologies are rapidly gaining traction in the Middle East and Africa, supported by a growing demand for improved healthcare solutions. The region's increasing healthcare expenditure and heightened focus on disease prevention contribute to the adoption of biomarker-based diagnostics.

Latin America exhibits a growing biomarker technologies market, fueled by the rising prevalence of chronic diseases and a growing awareness of personalized medicine. The region's expanding healthcare infrastructure and research initiatives are driving the demand for biomarker-based solutions, making it a notable contributor to market growth.

Leading Key Players in the Biomarker Technologies Industry:

Various key players in the market are actively engaging innovation and strategic partnerships to maintain their competitive edge. They are also investing in research and development to enhance the sensitivity and specificity of biomarker detection methods. Additionally, these companies are expanding their product portfolios to cover a broader range of biomarkers and applications, catering to the growing demand for personalized medicine. Collaborations with academic institutions and pharmaceutical companies are common, fostering the discovery and validation of novel biomarkers. Moreover, these market leaders are focused on complying with regulatory standards to ensure the safety and effectiveness of their biomarker-based products, ultimately shaping the future of diagnostics and treatment in healthcare.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Agilent Technologies Inc.

Bio-Rad Laboratories Inc.

Danaher Corporation

F. Hoffmann-La Roche AG

Illumina Inc.

LI-COR Inc.

Merck KGaA

PerkinElmer Inc.

QIAGEN N.V.

Shimadzu Corporation

Thermo Fisher Scientific Inc.

Waters Corporation

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Latest News:

August 30, 2022: Thermo Fisher Scientific, Inc. launched CE-IVD (IVDD) NGS test and analysis software to expand access to personalized oncology biomarker testing. This announcement underscores the company's commitment to advancing the accessibility and accuracy of molecular diagnostics for cancer patients. The CE-IVD certification is a crucial regulatory milestone, indicating that the NGS test and associated software meet the rigorous standards required for diagnostic use in Europe. This certification ensures the reliability and consistency of the test results, making them suitable for clinical decision-making.

December 4, 2023: Agilent Technologies Inc. announced the addition of water immersion and new confocal spinning disk technology to the BioTek Cytation C10 confocal imaging reader. These features improve image quality and results by reducing deleterious effects on live-cell samples and enhancing clarity for thicker samples such as tissues and 3-D spheroids. Agilent Technologies Inc.'s enhancement of the BioTek Cytation C10 confocal imaging reader underscores their commitment to providing cutting-edge solutions for live-cell imaging and advancing research in 3-D biological models.

November 22, 2023: Danaher Corporation's development of a comprehensive mRNA production ecosystem strengthens its position as a leading provider of integrated solutions for the biotechnology and pharmaceutical industries, facilitating the efficient production of mRNA therapeutics at various scales.

Key Questions Answered in This Report:

  • How has the global biomarker technologies market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global biomarker technologies market?
  • What is the impact of each driver, restraint, and opportunity on the global biomarker technologies market?
  • What are the key regional markets?
  • Which countries represent the most attractive biomarker technologies market?
  • What is the breakup of the market based on the test type?
  • Which is the most attractive test type in the biomarker technologies market?
  • What is the breakup of the market based on the indication?
  • Which is the most attractive indication in the biomarker technologies market?
  • What is the breakup of the market based on the product?
  • Which is the most attractive product in the biomarker technologies market?
  • What is the breakup of the market based on technology?
  • Which is the most attractive technology in the biomarker technologies market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the biomarker technologies market?
  • What is the competitive structure of the market?
  • Who are the key players/companies in the global biomarker technologies market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Biomarker Technologies Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Test Type

  • 6.1 Solid Biopsy
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Liquid Biopsy
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Indication

  • 7.1 Cancer
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Infectious Diseases
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Autoimmune Disorders
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Cardiovascular Disorders
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Product

  • 8.1 Consumables
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Assay
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Reagent
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Instruments
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Technology

  • 9.1 Polymerase Chain Reaction (PCR)
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Next Generation Sequencing (NGS)
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Immunoassay
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Application

  • 10.1 Drug Discovery
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Clinical Diagnostics
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Personalized Medicine
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia-Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Agilent Technologies Inc.
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
      • 16.3.1.3 Financials
      • 16.3.1.4 SWOT Analysis
    • 16.3.2 Bio-Rad Laboratories Inc.
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
      • 16.3.2.3 Financials
      • 16.3.2.4 SWOT Analysis
    • 16.3.3 Danaher Corporation
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
      • 16.3.3.3 Financials
      • 16.3.3.4 SWOT Analysis
    • 16.3.4 F. Hoffmann-La Roche AG
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
      • 16.3.4.3 Financials
    • 16.3.5 Illumina Inc.
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
      • 16.3.5.3 Financials
      • 16.3.5.4 SWOT Analysis
    • 16.3.6 LI-COR Inc.
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
    • 16.3.7 Merck KGaA
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
      • 16.3.7.3 Financials
      • 16.3.7.4 SWOT Analysis
    • 16.3.8 PerkinElmer Inc.
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
      • 16.3.8.3 Financials
      • 16.3.8.4 SWOT Analysis
    • 16.3.9 QIAGEN N.V.
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
      • 16.3.9.3 Financials
      • 16.3.9.4 SWOT Analysis
    • 16.3.10 Shimadzu Corporation
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
      • 16.3.10.3 Financials
      • 16.3.10.4 SWOT Analysis
    • 16.3.11 Thermo Fisher Scientific Inc.
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio
      • 16.3.11.3 Financials
      • 16.3.11.4 SWOT Analysis
    • 16.3.12 Waters Corporation
      • 16.3.12.1 Company Overview
      • 16.3.12.2 Product Portfolio
      • 16.3.12.3 Financials
      • 16.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Biomarker Technologies Market: Major Drivers and Challenges
  • Figure 2: Global: Biomarker Technologies Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Biomarker Technologies Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Biomarker Technologies Market: Breakup by Test Type (in %), 2023
  • Figure 5: Global: Biomarker Technologies Market: Breakup by Indication (in %), 2023
  • Figure 6: Global: Biomarker Technologies Market: Breakup by Product (in %), 2023
  • Figure 7: Global: Biomarker Technologies Market: Breakup by Technology (in %), 2023
  • Figure 8: Global: Biomarker Technologies Market: Breakup by Application (in %), 2023
  • Figure 9: Global: Biomarker Technologies Market: Breakup by Region (in %), 2023
  • Figure 10: Global: Biomarker Technologies (Solid Biopsy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Biomarker Technologies (Solid Biopsy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Biomarker Technologies (Liquid Biopsy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Biomarker Technologies (Liquid Biopsy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Biomarker Technologies (Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Biomarker Technologies (Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Biomarker Technologies (Infectious Diseases) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Biomarker Technologies (Infectious Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Biomarker Technologies (Autoimmune Disorders) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Biomarker Technologies (Autoimmune Disorders) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Biomarker Technologies (Cardiovascular Disorders) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Biomarker Technologies (Cardiovascular Disorders) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Biomarker Technologies (Other Indications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Biomarker Technologies (Other Indications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Biomarker Technologies (Consumables) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Biomarker Technologies (Consumables) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Biomarker Technologies (Assay) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Biomarker Technologies (Assay) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Biomarker Technologies (Reagent) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Biomarker Technologies (Reagent) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Biomarker Technologies (Instruments) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Biomarker Technologies (Instruments) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Biomarker Technologies (Polymerase Chain Reaction - PCR) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Biomarker Technologies (Polymerase Chain Reaction - PCR) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Biomarker Technologies (Next Generation Sequencing - NGS) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Biomarker Technologies (Next Generation Sequencing - NGS) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Global: Biomarker Technologies (Immunoassay) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Global: Biomarker Technologies (Immunoassay) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: Global: Biomarker Technologies (Other Technologies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: Global: Biomarker Technologies (Other Technologies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: Global: Biomarker Technologies (Drug Discovery) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: Global: Biomarker Technologies (Drug Discovery) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Global: Biomarker Technologies (Clinical Diagnostics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Global: Biomarker Technologies (Clinical Diagnostics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Global: Biomarker Technologies (Personalized Medicine) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Global: Biomarker Technologies (Personalized Medicine) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: North America: Biomarker Technologies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: North America: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: United States: Biomarker Technologies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: United States: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: Canada: Biomarker Technologies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: Canada: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: Asia-Pacific: Biomarker Technologies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: Asia-Pacific: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: China: Biomarker Technologies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: China: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Japan: Biomarker Technologies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Japan: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: India: Biomarker Technologies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: India: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: South Korea: Biomarker Technologies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: South Korea: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Australia: Biomarker Technologies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Australia: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: Indonesia: Biomarker Technologies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: Indonesia: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: Others: Biomarker Technologies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: Others: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Europe: Biomarker Technologies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Europe: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Germany: Biomarker Technologies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Germany: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: France: Biomarker Technologies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: France: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: United Kingdom: Biomarker Technologies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: United Kingdom: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Italy: Biomarker Technologies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Italy: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Spain: Biomarker Technologies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Spain: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Russia: Biomarker Technologies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Russia: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Others: Biomarker Technologies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: Others: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 84: Latin America: Biomarker Technologies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 85: Latin America: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 86: Brazil: Biomarker Technologies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 87: Brazil: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 88: Mexico: Biomarker Technologies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 89: Mexico: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 90: Others: Biomarker Technologies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 91: Others: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 92: Middle East and Africa: Biomarker Technologies Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 93: Middle East and Africa: Biomarker Technologies Market: Breakup by Country (in %), 2023
  • Figure 94: Middle East and Africa: Biomarker Technologies Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 95: Global: Biomarker Technologies Industry: SWOT Analysis
  • Figure 96: Global: Biomarker Technologies Industry: Value Chain Analysis
  • Figure 97: Global: Biomarker Technologies Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Biomarker Technologies Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Biomarker Technologies Market Forecast: Breakup by Test Type (in Million US$), 2024-2032
  • Table 3: Global: Biomarker Technologies Market Forecast: Breakup by Indication (in Million US$), 2024-2032
  • Table 4: Global: Biomarker Technologies Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 5: Global: Biomarker Technologies Market Forecast: Breakup by Technology (in Million US$), 2024-2032
  • Table 6: Global: Biomarker Technologies Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 7: Global: Biomarker Technologies Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 8: Global: Biomarker Technologies Market: Competitive Structure
  • Table 9: Global: Biomarker Technologies Market: Key Players